NBP162381

Polypeptide GalNac Transferase 4/GALNT4 Antibody, Novus Biologicals™

Manufacturer: Novus Biologicals

Select a Size

Pack Size SKU Availability Price
Each of 1 NBP162381-Each-of-1 In Stock ₹ 42,737.22

NBP162381 - Each of 1

₹ 42,737.22

In Stock

Quantity

1

Base Price: ₹ 42,737.22

GST (18%): ₹ 7,692.70

Total Price: ₹ 50,429.92

Antigen

Polypeptide GalNac Transferase 4/GALNT4

Classification

Polyclonal

Conjugate

Unconjugated

Formulation

PBS, 2% Sucrose with 0.09% Sodium Azide

Gene Alias

EC 2.4.1.41, FLJ93314, GALNACT4, GALNAC-T4, Polypeptide GalNAc transferase 4, polypeptide N-acetylgalactosaminyltransferase 4, pp-GaNTase 4, Protein-UDP acetylgalactosaminyltransferase 4, UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 4, UDP-N-acetyl-alpha-D-galactosamine:polypeptideN-acetylgalactosaminyltransferase 4 (GalNAc-T4)

Host Species

Rabbit

Molecular Weight of Antigen

67 kDa

Quantity

100 μL

Primary or Secondary

Primary

Reconstitution

Centrifuge the vial of lyoph antibody at 12,000 x g for 20 seconds. Add 50μL of distilled water. Vortex followed by centrifuge again to pellet the solution.Final concentration is 1mg/mL in PBS buffer.

Content And Storage

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Applications

Western Blot

Concentration

0.5 mg/ml

Dilution

Western Blot 1.0 ug/ml

Gene Accession No.

Q8N4A0

Gene Symbols

GALNT4

Immunogen

Synthetic peptides corresponding to GALNT4(UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4)) The peptide sequence was selected from the middle region of GALNT4. Peptide sequence VGHVFPKRAPYARPNFLQNTARAAEVWMDEYKEHFYNRNPPARKEAYGDI The peptide sequence for this immunogen was taken from within the described region.

Purification Method

Affinity purified

Regulatory Status

RUO

Gene ID (Entrez)

8693

Target Species

Human, Mouse, Rat, Porcine, Bovine, Equine, Zebrafish

Isotype

IgG

Related Products

Img

Novus Biologicals

NBP159681

--

Img

Novus Biologicals

NBP162417

--

Img

Novus Biologicals

NBP159863

--

Img

Novus Biologicals

NBP162245

--

Img

Novus Biologicals

NBP169014

--

Img

Novus Biologicals

NBP159526

--

Img

Novus Biologicals

NBP169019

--

Img

Novus Biologicals

NBP16237220

--

Description

  • Polypeptide GalNac Transferase 4/GALNT4 Polyclonal specifically detects Polypeptide GalNac Transferase 4/GALNT4 in Human samples
  • It is validated for Western Blot.

Compare Similar Items

Show Difference

Img

Novus Biologicals

NBP162381

--


Antigen:
Polypeptide GalNac Transferase 4/GALNT4

Classification:
Polyclonal

Conjugate:
Unconjugated

Formulation:
PBS, 2% Sucrose with 0.09% Sodium Azide

Gene Alias:
EC 2.4.1.41, FLJ93314, GALNACT4, GALNAC-T4, Polypeptide GalNAc transferase 4, polypeptide N-acetylgalactosaminyltransferase 4, pp-GaNTase 4, Protein-UDP acetylgalactosaminyltransferase 4, UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 4, UDP-N-acetyl-alpha-D-galactosamine:polypeptideN-acetylgalactosaminyltransferase 4 (GalNAc-T4)

Host Species:
Rabbit

Molecular Weight of Antigen:
67 kDa

Quantity:
100 μL

Primary or Secondary:
Primary

Reconstitution:
Centrifuge the vial of lyoph antibody at 12,000 x g for 20 seconds. Add 50μL of distilled water. Vortex followed by centrifuge again to pellet the solution.Final concentration is 1mg/mL in PBS buffer.

Content And Storage:
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Applications:
Western Blot

Concentration:
0.5 mg/ml

Dilution:
Western Blot 1.0 ug/ml

Gene Accession No.:
Q8N4A0

Gene Symbols:
GALNT4

Immunogen:
Synthetic peptides corresponding to GALNT4(UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4)) The peptide sequence was selected from the middle region of GALNT4. Peptide sequence VGHVFPKRAPYARPNFLQNTARAAEVWMDEYKEHFYNRNPPARKEAYGDI The peptide sequence for this immunogen was taken from within the described region.

Purification Method:
Affinity purified

Regulatory Status:
RUO

Gene ID (Entrez):
8693

Target Species:
Human, Mouse, Rat, Porcine, Bovine, Equine, Zebrafish

Isotype:
IgG

Img

Fischer Scientific

NBP162385

--


Antigen:
BRI3BP

Classification:
Polyclonal

Conjugate:
Unconjugated

Formulation:
PBS, 2% Sucrose with 0.09% Sodium Azide

Gene Alias:
BNAS1, BRI3 binding protein, BRI3-binding protein, Cervical cancer 1 proto-oncogene-binding protein KG19, cervical cancer oncogene binding protein, HCCR-1, HCCR-2, HCCRBP-1, KG19I3-binding protein

Host Species:
Rabbit

Molecular Weight of Antigen:
28 kDa

Quantity:
100 μL

Primary or Secondary:
Primary

Reconstitution:
Centrifuge the vial of lyoph antibody at 12,000 x g for 20 seconds. Add 50μL of distilled water. Vortex followed by centrifuge again to pellet the solution.Final concentration is 1mg/mL in PBS buffer.

Content And Storage:
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Applications:
Western Blot

Concentration:
0.5 mg/ml

Dilution:
Western Blot 1.0 ug/ml

Gene Accession No.:
Q8WY22

Gene Symbols:
BRI3BP

Immunogen:
Synthetic peptides corresponding to BRI3BP(BRI3 binding protein) The peptide sequence was selected from the C terminal of BRI3BP. Peptide sequence GFYWRSSPSGPSNPSNPSVEEKLEHLEKQVRLLNIRLNRVLESLDRSKDK.

Purification Method:
Affinity purified

Regulatory Status:
RUO

Gene ID (Entrez):
140707

Target Species:
Human, Mouse, Rat, Bovine, Equine, Guinea Pig, Rabbit

Isotype:
IgG

Img

Fischer Scientific

NBP16238520

--


Antigen:
BRI3BP

Classification:
Polyclonal

Conjugate:
Unconjugated

Formulation:
PBS and 2% Sucrose with 0.09% Sodium Azide

Gene Alias:
BNAS1, BRI3 binding protein, BRI3-binding protein, Cervical cancer 1 proto-oncogene-binding protein KG19, cervical cancer oncogene binding protein, HCCR-1, HCCR-2, HCCRBP-1, KG19I3-binding protein

Host Species:
Rabbit

Molecular Weight of Antigen:
28 kDa

Quantity:
20 μL

Primary or Secondary:
Primary

Reconstitution:
__

Content And Storage:
Store at -20C. Avoid freeze-thaw cycles.

Applications:
Western Blot

Concentration:
__

Dilution:
Western Blot 1:100-1:2000

Gene Accession No.:
Q8WY22

Gene Symbols:
BRI3BP

Immunogen:
Synthetic peptides corresponding to BRI3BP(BRI3 binding protein) The peptide sequence was selected from the C terminal of BRI3BP. Peptide sequence GFYWRSSPSGPSNPSNPSVEEKLEHLEKQVRLLNIRLNRVLESLDRSKDK.

Purification Method:
Affinity Purified

Regulatory Status:
RUO

Gene ID (Entrez):
140707

Target Species:
Human

Isotype:
IgG

Img

Fischer Scientific

NBP162387

--


Antigen:
CYP3A7

Classification:
Polyclonal

Conjugate:
Unconjugated

Formulation:
PBS, 2% Sucrose with 0.09% Sodium Azide

Gene Alias:
CYPIIIA7, cytochrome P450, family 3, subfamily A, polypeptide 7, Cytochrome P450-HFLA, EC 1.14.14.1, flavoprotein-linked monooxygenase, microsomal monooxygenase, subfamily IIIA, polypeptide 7, xenobiotic monooxygenase

Host Species:
Rabbit

Molecular Weight of Antigen:
57 kDa

Quantity:
100 μL

Primary or Secondary:
Primary

Reconstitution:
Centrifuge the vial of lyoph antibody at 12,000 x g for 20 seconds. Add 100μL of distilled water. Vortex followed by centrifuge again to pellet the solution.Final concentration is 1mg/mL in PBS buffer.

Content And Storage:
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Applications:
Western Blot

Concentration:
1 mg/ml

Dilution:
Western Blot 1.0 ug/ml

Gene Accession No.:
P24462

Gene Symbols:
CYP3A7

Immunogen:
Synthetic peptides corresponding to CYP3A7(cytochrome P450, family 3, subfamily A, polypeptide 7) The peptide sequence was selected from the middle region of CYP3A7. Peptide sequence KSVKQIKEGRLKETQKHRVDFLQLMIDSQNSKDSETHKALSDLELMAQSI.

Purification Method:
Protein A purified

Regulatory Status:
RUO

Gene ID (Entrez):
1551

Target Species:
Human, Rat, Bovine, Canine, Guinea Pig

Isotype:
IgG